To evaluate the efficacy of cetuximab combined with modified FOLFIRI (mFOLFIRI) as a second-line treatment in metastatic gastric cancer patients and to identify potential biomarkers of clinical outcomes.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mH8qNH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
2 Peter 1:5 Now for this very reason also, applying all diligence, in your faith supply moral excellence, and in your moral excellence, know...
-
20 Passive Income Ideas To Build Real Wealth. Last Updated on February 2, 2017 Alexa Mason 7 Comments We may receive compensation from affil...
-
In the Democratic Republic of the Congo the control of hypertension is poor, characterized by an increasing number of reported cases of hype...
-
Music: Elton John: Lyrics: Bernie Taupin: piano and vocals: Elton John: drums: Barry Morgan: bass guitar: Dave Richmond: acoustic guitar: Fr...
-
Information on properly formatting papers and citing sources in several different styles. How to cite legal material in APA style from #Al...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2peztQn via IFTTT
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o9qcdh via IFTTT
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nRV68U via IFTTT
-
Root of Jurenia dolomiaea is used traditionally in various disorders involving oxidative injuries i.e. rheumatism, gout and as stimulant. Ea...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου